Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

BOSTON, January 07, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 a.m. ET/8:15 a.m. PT.

Related Keywords

Canada ,Australia ,Saudi Arabia ,Switzerland ,Bahrain ,United States ,United Kingdom ,Boston ,Massachusetts ,London ,City Of ,Kingdom Of Saudi Arabia ,Great Britain ,America ,Heather Nichols ,Reshma Kewalramani ,Companies To Work ,Linkedin ,Instagram ,Facebook ,European Medicines Agency ,Vertex Pharmaceuticals Incorporated Nasdaq ,Youtube ,Exchange Commission ,Vertex Pharmaceuticals Incorporated ,Healthcare Products Regulatory Agency ,Health Canada ,Healthcare Conference ,Chief Executive Officer ,Cell Disease ,Transfusion Dependent Beta Thalassemia ,Prescription Drug User Fee Act ,Synergie Medication Collective ,Blue Cross ,Blue Shield ,Neuropathic Pain ,Mediated Kidney Disease ,Dystrophy Type ,Clinical Trial Applications ,Investigational New Drug ,Dominant Polycystic Kidney Disease ,Healthcare Conference Presentation ,North America ,Top Employers ,Private Securities Litigation Reform Act ,